Retail Investors Are Guangzhou Wondfo Biotech Co.,Ltd's (SZSE:300482) Biggest Owners and Were Hit After Market Cap Dropped CN¥645m

Simply Wall StNov 15 17:19 ET

Is Guangzhou Wondfo BiotechLtd (SZSE:300482) A Risky Investment?

Simply Wall StOct 28 23:09 ET

Wanfu Biotech: Report for the third quarter of 2024

SZSIOct 24 12:00 ET · Announcements

guangzhou wondfo biotech (300482.SZ) released its performance for the first three quarters, with a net income of 0.436 billion yuan, an increase of 9.04%.

Guangzhou Wondfo Biotech (300482.SZ) released its third-quarter report for 2024, with the company's revenue for the first three quarters reaching 2...

Zhitong FinanceOct 24 05:12 ET

The Market Lifts Guangzhou Wondfo Biotech Co.,Ltd (SZSE:300482) Shares 40% But It Can Do More

Simply Wall StOct 8 18:57 ET

Guangzhou Wondfo Biotech (300482.SZ): The new coronavirus home testing (OTC) product has received pre-market notification from the USA FDA.

GeLongHui October 8th | guangzhou wondfo biotech (300482.SZ) announced that the company recently received a notification from the USA Food & Drug Administration (USA Food and Drug Administration, hereinafter referred to as "FDA"), notifying that guangzhou wondfo biotech's new coronavirus family test kit (OTC version) Wondfo 2019-nCoV Antigen Test (Lateral Flow Method) has received a US FDA 510(K) pre-market notification. The company's new coronavirus family test (OTC) kit.

Gelonghui FinanceOct 8 04:16 ET